The shares of the pharmaceutical manufacturer JSC Olainfarm could be delisted from the Nasdaq Riga stock exchange at the beginning of next year, according to the information provided by the company to the stock exchange.
Representatives of Olainfarm mention that the mandatory share repurchase offer started on November 8, 2021 and will end on December 7. After that, within five working days, ie until December 14, a report on the results of the share repurchase will be published in the official publication “Latvijas Vēstnesis” and settlements will be made with the shareholders who have accepted the share repurchase offer.
In turn, not earlier than within ten 10 and not later than 15 working days from the publication of the report on the results of the offer in the Latvian Gazette, ie approximately from December 29 to January 6, 2022, Olainfarm will submit to Nasdaq Riga an application for delisting of shares. After that, the Board of Nasdaq Riga will make a decision to delist Olainfarm shares from the regulated market within 10 business days, ie by January 20, 2022.
It has already been reported that on November 8, the mandatory offer to repurchase the shares of Olainfarm, expressed by the parent company of the Repharm Group AS AB City, will start. The price of one share in the mandatory share repurchase offer is set at 9.26 euros.